(Q40845510)

24 September 2017

title

Study of beta-lactam resistance in ceftazidime-resistant clinical isolates of Enterobacteriaceae (English)

1 reference

24 September 2017

Enterobacteriaceae

1 reference

Bujdáková H

1

1 reference

24 September 2017

Lausová A

2

1 reference

24 September 2017

Jankovicová S

3

1 reference

24 September 2017

Prodinger WM

4

1 reference

24 September 2017

Kallová J

5

1 reference

24 September 2017

Milosovic P

6

1 reference

24 September 2017

Kettner M

7

1 reference

24 September 2017

publication date

1 May 1998

1 reference

International Journal of Antimicrobial Agents

24 September 2017

published in

1 reference

24 September 2017

volume

10

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

135-141

1 reference

TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Evolution of plasmid-coded resistance to broad-spectrum cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Characterization of the plasmid mediated beta-lactamase BIL-1

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Changing patterns of bacterial nosocomial infections: a nine-year study in a general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Survey of prevalence of extended spectrum beta-lactamases among enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Transferable amikacin resistance in gram-negative bacterial isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

beta-Lactam resistance amongst Enterobacter species

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Is it important to identify extended-spectrum beta-lactamase-producing isolates?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

Genetics of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900027-2

7 January 2021

10.1016/S0924-8579(98)00027-2

Identifiers

DOI

1 reference

24 September 2017

1 reference